Join a diverse group of stakeholders – public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others – for this two-day conference on effectively regulating the broad spectrum of tobacco and nicotine products in the US. Attendees will hear directly from FDA about the latest updates on regulations, guidance documents, and other initiatives. The conference will also include numerous discussions of timely tobacco and nicotine product issues and feature interactive dialogues between the panelists and audience.

Planning Committee

Committee Members 

Tony Abboud, Vapor Technology Association
Jasjit Ahluwalia, Brown University
Maham Akbar, Truth Initiative
Aruni Bhatnagar, University of Louisville School of Medicine
Shelly Blackwell, EAS Consulting Group
Brittani Cushman, Turning Point Brands, Inc
Clifford E. Douglas, University of Michigan
Connor Fuchs, Campaign for Tobacco-Free Kids
Joe G. Gitchell, Pinney Associates, Inc.
Matthew R. Holman, Philip Morris International
Eshael Johnson, FDA
Rima Khoury, Fumari, Inc.
Jaron King, South Carolina Department of Health and Environmental Control
John L Marshall, Altria Client Services LLC
Daniel P. McGee, Keller and Heckman
William A. McGrath, Potomac Law Group
Brian J. Miller, Johns Hopkins University
Stefanie Miller, JUUL Labs
John O’Brien, RAI Services Company
Elizabeth Oestreich, Greenleaf Health, Inc.
John Pritchard, 22nd Century Group, Inc.
Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
Henry Roemer, Finger, Roemer, Brown & Mariani LLP
Barry Schaevitz, Fox Rothschild LLP
Jim Solyst, JMS Scientific Engagement
Mark J. Vaders, Womble Bond Dickinson (US) LLP